Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Theriva Biologics, Inc. (TOVX) had Cash Flow from Financial Activities of $3.85M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-3.22M |
|
-- |
|
-- |
|
$3.29M |
|
$-3.29M |
|
$0.08M |
|
$-3.22M |
|
$-3.22M |
|
$-3.22M |
|
$-3.22M |
|
$-3.22M |
|
$-3.22M |
|
$-3.29M |
|
$-3.27M |
|
45.89M |
|
45.89M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$13.67M |
|
$0.17M |
|
$21.19M |
|
$34.86M |
|
$12.11M |
|
$1.62M |
|
$10.56M |
|
$22.67M |
|
$12.19M |
|
$12.19M |
|
$12.19M |
|
45.89M |
|
| Cash Flow Statement Financials | |
$-5.54M |
|
$-0.00M |
|
|
Cash Flow from Financial Activities |
$3.85M |
$13.10M |
|
$11.38M |
|
$-1.72M |
|
$0.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.13 |
|
-- |
|
-- |
|
0.12 |
|
0.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.54M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-26.40% |
|
-26.40% |
|
-9.23% |
|
-23.30% |
|
$0.27 |
|
$-0.12 |
|
$-0.12 |
|